However, the immuno-effector cells in the anti-tumor mechanism of the PE(ΔIII)/E7 fusion protein vaccine include CD4+ helper T lymphocytes, CD8+ cytotoxic T lymphocytes, and NK cells [15]. Here, CD8A is linked to neoplasm.